ClinicalTrials.gg
RecruitingNCT07078565Updated Jul 22, 2025

Tai Chi vs. Modified-Otago Exercises for Pain, Balance, and Motor Function in Diabetic Peripheral Neuropathy

An interventional study of Modified-Otago Exercises and Tai Chi in Diabetic Peripheral Neuropathy (DPN) and Type 2 Diabetes Mellitus (T2DM), sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-07-22.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as recruiting.
  • Registered 5 months after the study started (first participant enrolled Jan 2025, registered Jul 2025).
  • Started Jan 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Diabetes Mellitus, Type 2 by Riphah International University — 6 open to participants now, 6 under way, none of them phase 3. Diabetes Mellitus, Type 2 · Riphah International University.

Planned enrollment
12th of 19
36 · median 46
Started
2025
with 3 others
No phase
19 of 19
6 open now
Registered
13th of 19
by date

Among the 19 studies in Diabetes Mellitus, Type 2 by Riphah International University, this one is the 12th largest by planned enrollment, is one of 4 that started in 2025, is one of 19 with no phase, and was the 13th registered.

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

6 of the 19 studies in Diabetes Mellitus, Type 2 by Riphah International University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 40 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Diabetes Mellitus, Type 2 by Riphah International University, or all of them as a file.
02

Study summary

his randomized clinical trial evaluates the comparative effectiveness of Tai Chi and Modified-Otago exercise programs on pain reduction, balance improvement, and motor function in patients diagnosed with diabetic peripheral neuropathy (DPN). DPN is a common complication of Type 2 Diabetes Mellitus that significantly impairs quality of life through chronic pain, balance deficits, and decreased functional mobility. While pharmacological treatments are commonly used, they often result in adverse side effects, creating a growing need for non-pharmacological interventions like therapeutic exercises.

Tai Chi, a traditional Chinese exercise combining slow movements and mental focus, has shown benefits in improving mobility and reducing fall risks in chronic disease populations. The Modified-Otago program, originally developed to prevent falls in the elderly, emphasizes strength and balance training through structured exercise routines.

A total of 36 participants (aged 40-80 years) with at least a 5-year history of Type 2 diabetes and a minimum pain score of ≥3 on the Numeric Pain Rating Scale (NPRS) will be recruited. Participants will be randomly allocated to either the Tai Chi group or the Modified-Otago group. Both groups will receive 24 sessions over an 8-week period (3 sessions per week), along with baseline interventions such as heating pad application, TENS, and warm-up/cool-down routines.

Primary outcome measures include NPRS for pain, the Berg Balance Scale (BBS) for balance, and the Dynamic Gait Index (DGI) for motor function. Assessments will be conducted at baseline, post-intervention, and two weeks post-treatment. Data will be analyzed using SPSS version 26 to determine within-group and between-group differences.

This study aims to inform clinicians about effective exercise strategies for improving physical function in patients with DPN and potentially establish evidence-based rehabilitation protocols.

Read the detailed description

Diabetic Peripheral Neuropathy (DPN) is a chronic complication of diabetes characterized by pain, numbness, and impaired balance. It frequently leads to limitations in mobility and increased fall risk, significantly affecting patients' independence and quality of life. Standard treatments often include pharmacological agents, but their long-term use is associated with adverse effects. As a result, non-drug interventions like exercise are increasingly being promoted as safer and equally effective alternatives.

Tai Chi and Modified-Otago exercise programs have individually shown promise in populations with mobility impairments. Tai Chi integrates slow, controlled movements with breathing and mindfulness, making it suitable for elderly individuals or those with chronic conditions. The Modified-Otago program was specifically designed to prevent falls through strength and balance training. While both interventions are beneficial independently, no study has yet compared their relative efficacy in managing symptoms of DPN.

03

Conditions studied

  • Diabetic Peripheral Neuropathy (DPN)
  • Type 2 Diabetes Mellitus (T2DM)

Keywords

  • Diabetic Peripheral Neuropathy
  • Tai Chi
  • Modified-Otago Exercises
  • Balance Training
04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Both genders are aged 40-80 years
  • Patient having Types ii diabetes with Minimum of 5 years since diabetes diagnosis
  • Patients experiencing chronic pain for at least 6 months and level ≥ 3 on NPRS.
  • Patient having ≥ 6 score on Toronto Clinical Neuropathy Scoring System for diabetic neuropathy

Exclusion criteria

Exclusion Criteria:

  • Non-ambulatory patients
  • Patients with ulceration/infection of feet, medical/surgical conditions
  • Patients suffering from stroke, parkinson's disease, or multiple sclerosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Tai Chi

    Participants in this group will receive Tai Chi-based therapeutic exercise sessions, including joint mobility, balance, flexibility, and strength training movements (e.g., Qigong and bow stance).

    Other: Tai Chi

  • Experimental
    Modified-Otago Exercises

    Participants in this group will receive the Modified-Otago Exercise Program focused on strength and balance training through functional exercises like stair walking, knee bends, and toe raises.

    Other: Modified-Otago Exercises

Interventions

  • OtherModified-Otago Exercises

    Intervention is administered 3 times per week for 4 weeks, with the same baseline therapy as the Tai Chi group.

  • OtherTai Chi

    Intervention is administered 3 times per week for 4 weeks, along with baseline therapy (TENS + heating pad).

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), which rates pain on a scale from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: 4 weeks

Secondary outcomes

  1. Balance

    Balance will be assessed using the Berg Balance Scale (BBS), a 14-item scale that evaluates static and dynamic balance in older adults.

    Time frame: 4 weeks

  2. Gait Performance

    Motor function and dynamic walking ability will be measured using the Dynamic Gait Index (DGI), which assesses an individual's ability to modify gait in response to changing task demands.

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Riphah Rehab Training and Research Center,
    Lahore, Punjab Province 54000, Pakistan
    Recruiting
    • Dr. Ali Raza, MS-OMPT · Contactaraza.frahs@riphah.edu.pk
    • Nadeem Leo · Contact03000722941
    • Arshia Ijaz, DPT · Principal investigator
08

References and documents

Individual participant data

Plan to share: No — The individual participant data (IPD) will not be shared due to institutional policies, ethical considerations, and privacy concerns. All data will be kept confidential and used solely for the purposes of this stud

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Nov 2025, 10 months after the start.

Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 10 months is below that.

Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2025
First posted
Jul 22, 2025
StartActual
Jan 25, 2025
Primary completionEst.
Nov 30, 2025
CompletionEst.
Dec 30, 2025
Last update
Jul 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07078565
Responsible party
Sponsor
First posted
Jul 22, 2025
Start date
Jan 25, 2025
Primary completion
Nov 30, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Jul 22, 2025

Study contacts

Imran Amjad, PhD
Contact
imran.amjad@riphah.edu.pk
03324390125
Amna Shahid, t-DPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion